Clinical trial
Phase II/III Study of WST09 in Prostate Cancer After Radiation Therapy
NCT00312442 · STEBA France, Industry · Terminated
Key facts
| NCT number | NCT00312442 |
|---|---|
| Title | Phase II/III Study of WST09 in Prostate Cancer After Radiation Therapy |
| Official title | Study of Photodynamic Therapy With WST09 in Patients With Recurrent or Persistent Localized Carcinoma of the Prostate Following Radiation Therapy |
| Lead sponsor | STEBA France, Industry |
| Status | Terminated |
| Phase | Phase 2/Phase 3 |
| Study type | Interventional |
| Conditions | Prostate Cancer |
| Intervention type | Drug |
| Interventions | Treatment with WST09 Vascular Photodynamic therapy |
| Enrollment | 16 |
| Start date | May 1, 2006 |
| Primary completion | Jul 1, 2008 |
| Completion | Dec 1, 2009 |
| First posted | Apr 10, 2006 |
| Last update posted | Jun 2, 2010 |
| Countries | Canada |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: